HSPA1A and Alzheimer disease: Intranasal treatment with recombinant HSP70 (rHSP70) in a transgenic mouse model of AD reportedly decreased the accumulation of Aβ proteins and prevented neurodegeneration in the hippocampus and cortex [265].